Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GPD-C52D3 | Cynomolgus | Cynomolgus GPRC5D Protein, Flag,His Tag | ![]() |
![]() ![]() |
![]() ![]() |
GPD-HF2P7 | Human | Fluorescent Human GPRC5D Full Length Protein-VLP (HEK293) |
![]() ![]() |
||
GPD-C82D4 | Cynomolgus | Cynomolgus GPRC5D Protein, Flag,His Tag (Nanodisc) | ![]() |
![]() ![]() |
![]() ![]() |
GPD-H82D6 | Human | Biotinylated Human GPRC5D Protein, His,Avitag™&Flag Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
GPD-H52P5 | Human | Human GPRC5D Full Length Protein-VLP (HEK293) |
![]() ![]() |
||
GPD-H52D3 | Human | Human GPRC5D Protein, Flag,His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
GPD-H52D4 | Human | Human GPRC5D Protein, Flag,His Tag (Nanodisc) | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Anti-GPRC5D antibody immobilized on CM5 Chip can bind Cynomolgus GPRC5D, Flag,His Tag (Cat. No. GPD-C52D3) with an affinity constant of 0.346 μM as determined in a SPR assay (Biacore 8K) (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
MCARH-109 | Phase 1 Clinical | Memorial Sloan Kettering Cancer Center | Multiple Myeloma | Details | |
Talquetamab | JNJ-64407564; JNJ-7564 | Phase 2 Clinical | Janssen Global Services Llc, Genmab | Hematologic Neoplasms; Multiple Myeloma | Details |
CAR-GPRC5D | Nanjing Iaso Biotherapeutics Co Ltd | Details |
This web search service is supported by Google Inc.